Antibody (1)
온라인 (1)
Rabbit (1)
- (1)
Unconjugated (1)
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| IMAB-027 | ASP-1650; IMAB-027 | Phase 2 Clinical | Ganymed | Ovarian Neoplasms; Neoplasms; Neoplasms, Germ Cell and Embryonal | 상세 |
| TORL-1-23 | TORL-1-23 | Phase 2 Clinical | Torl Biotherapeutics LLC | Ovarian Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Endometrial Neoplasms; Peritoneal Diseases; Carcinoma, Non-Small-Cell Lung | 상세 |
| BNT-142 | BNT-142 | Phase 2 Clinical | Biontech Se | Solid tumours | 상세 |
| CTIM-76 | CTIM-76 | Phase 1 Clinical | Integral Molecular Inc | Ovarian Neoplasms; Solid tumours; Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | 상세 |
| NBL-028 | NBL028; NBL-028 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd, Novarock Biotherapeutics Ltd | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Testicular Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | 상세 |
| XmAb-541 | XmAb541; XmAb-541 | Phase 1 Clinical | Xencor Inc | Ovarian Neoplasms; Ovarian germ cell tumor; Germinoma; Endometrial Neoplasms; Neoplasms, Germ Cell and Embryonal | 상세 |
| CLDN6-CAR-NK Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Ovarian Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | 상세 | |
| DS-9606a | DS-9606a; DS-9606-a | Phase 1 Clinical | Daiichi Sankyo Inc | Ovarian Neoplasms; Neoplasms; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal | 상세 |
| AMG-794 | AMG-794 | Phase 1 Clinical | Amgen Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung | 상세 |
| CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Phase 1 Clinical | Biontech Se | Solid tumours | 상세 |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



